Invention Grant
- Patent Title: Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising gag, pol, vif and nef epitopes
-
Application No.: US15970216Application Date: 2018-05-03
-
Publication No.: US11325946B2Publication Date: 2022-05-10
- Inventor: Christian Brander , Beatriz Mothe Pujadas , Anuska Llano
- Applicant: LABORATORIOS DEL DR. ESTEVE S.A. , FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDA—CAIXA
- Applicant Address: ES Barcelona; ES Badalona
- Assignee: LABORATORIOS DEL DR. ESTEVE S.A.,FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDA—CAIXA
- Current Assignee: LABORATORIOS DEL DR. ESTEVE S.A.,FUNDACIÓ PRIVADA INSTITUT DE RECERCA DE LA SIDA—CAIXA
- Current Assignee Address: ES Barcelona; ES Badalona
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: EP12382031 20120127
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K39/12 ; A61K39/21 ; C12N7/00 ; A61K39/00
Abstract:
The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.
Public/Granted literature
- US20190055289A1 IMMUNOGENS FOR HIV VACCINATION Public/Granted day:2019-02-21
Information query
